Health Care

The advocacy organization is welcoming the for-profit takeover of its members’ national health insurance program — because it earns hundreds of millions as part of the deal

While all eyes were on Eli Lilly’s stock price last week, the struggles of an insulin pump manufacturer will have far more troubling implications for diabetics.

Despite the Affordable Care Act’s promises, publicly subsidized insurers are jacking up prices while Americans lose coverage.